The Qualcomm-backed electronics maker will float the bottom of its range, in an offering that is still the largest for a tech company since 2014.

The live video streaming platform, which is backed by Kunlun Tech, Duomi and Tencent, has set the terms for its initial public offering.

The messenger RNA drug developer, backed by Monsanto, Merck & Co, GlaxoSmithKline, Pfizer and Merck Group, has raised more than $121m in its initial public offering.

Johns Hopkins-backed biopharmaceutical developer Allakos has filed for a $75m initial public offering after raising more than $160m in equity funding.

UC Investment Office-backed gene expression technology developer Constellation Pharmaceuticals has filed for an $86.3m initial public offering.

SR One-backed gene expression technology developer Constellation Pharmaceuticals has filed for an $86.3m initial public offering.

Roche and Novo-backed biopharmaceutical developer Allakos has filed for a $75m initial public offering after raising more than $160m in equity funding.

The Merck GHI-backed medical device developer had raised $120m in funding prior to its initial public offering.

The online automotive retail platform is targeting $300m in an offering that will score exits for Tencent, Didi Chuxing and Taikang Life.

Onyx Therapeutics-backed autoimmune drug developer Kezar Life Sciences has closed its initial public offering at $86.3m.